BSL
SGXRaffles Medical Group Ltd
Health CareSingapore
Financial Summary
| Metric | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| Revenue | $765.3M | $751.6M | $706.9M | $766.5M |
| EBITDA | - | - | - | - |
| Net Profit | $70.6M | $62.2M | $90.2M | $143.5M |
| EPS | - | - | - | - |
| DPS | - | - | - | - |
Balance Sheet
Total Assets$1.2B
Total Liabilities-
Equity$1.1B
Net Debt$-218.3M
Cash$310.8M
NTA/Share-
FY25
Price Chart
Insufficient price data
Key Metrics
P/E Ratio26.14
P/B Ratio1.74
EV/EBITDA12.19
Dividend Yield-
ROE6.7%
ROA3.8%
Net Margin9.2%
Debt/Equity0.09
Net Debt/EBITDA-1.64
FCF Yield2.6%
Governance Score
-
SGX Code of Corporate Governance
StocksSG provides data for informational purposes only. This is not financial advice. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.